Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.
dc.contributor.author | Robinson, Liam![]() |
|
dc.contributor.author | Fonseca, Felipe Paiva![]() |
|
dc.contributor.author | Van Heerden, Willem Francois Petrus![]() |
|
dc.date.accessioned | 2022-01-20T08:59:29Z | |
dc.date.issued | 2021-07 | |
dc.description.abstract | Immunosuppressed patients may be affected by a wide range of lymphoproliferative disorders (LPDs) ranging from self-limiting disorders to malignant lymphoid proliferations. These LPDs may be associated with systemic immune disorders, develop following organ transplantation or occur in the background of other forms of iatrogenic immunosuppression. Lymphotropic viruses, including Epstein-Barr virus (EBV) and human herpesvirus-8 (HHV8), have been associated with the pathogenesis of distinct LPDs. The resulting classification of this group of disorders is very complex and inconsistent, with several new and emerging entities. Consequently, the diagnosis of an LPD, especially in an immunosuppressed patient, and its subsequent clinical management usually represent an important pitfall in daily clinical and pathology work. Therefore, the aim of this review was to use the available literature to describe the clinicopathological features of the most important benign LPDs that may be diagnosed in the head and neck region of immunosuppressed patients. Original clinical and microscopic images were used to illustrate some of these entities. | en_ZA |
dc.description.department | Oral Pathology and Oral Biology | en_ZA |
dc.description.embargo | 2022-06-07 | |
dc.description.librarian | hj2022 | en_ZA |
dc.description.uri | http://wileyonlinelibrary.com/journal/jop | en_ZA |
dc.identifier.citation | Robinson L, Fonseca FP, van Heerden WFP. Benign lymphoproliferative disorders in the immunosuppressed patient: an update. Journal of Oral Pathology and Medicine 2021;50:540– 547. https://doi.org/10.1111/jop.13204. | en_ZA |
dc.identifier.issn | 0904-2512 (print) | |
dc.identifier.issn | 1600-0714 (online) | |
dc.identifier.other | 10.1111/jop.13204 | |
dc.identifier.uri | http://hdl.handle.net/2263/83404 | |
dc.language.iso | en | en_ZA |
dc.publisher | Wiley | en_ZA |
dc.rights | © 2021 John Wiley & Sons A/S. This is the pre-peer reviewed version of the following article : Benign lymphoproliferative disorders in the immunosuppressed patient: an update. Journal of Oral Pathology and Medicine 2021;50:540– 547. https://doi.org/10.1111/jop.13204. The definite version is available at : http://wileyonlinelibrary.com/journal/jop. | en_ZA |
dc.subject | Epstein-Barr virus (EBV) | en_ZA |
dc.subject | Human herpesvirus-8 (HHV8) | en_ZA |
dc.subject | Human immunodeficiency virus (HIV) | en_ZA |
dc.subject | Immunosuppressed | en_ZA |
dc.subject | Lymphoproliferative disorder (LPD) | en_ZA |
dc.title | Benign lymphoproliferative disorders in the immunosuppressed patient: an update | en_ZA |
dc.type | Postprint Article | en_ZA |